Bernhard Volz
Friedrich-Alexander-Universität Erlangen-Nürnberg(DE)Georg Simon Ohm University of Applied Sciences Nuremberg(DE)Ansbach University of Applied Sciences(DE)Comprehensive Cancer Center Erlangen(DE)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Breast Cancer Treatment Studies, Advanced Breast Cancer Therapies, Cancer Treatment and Pharmacology, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status(2021)86 cited
- → Mutations in BRCA1/2 and Other Panel Genes in Patients With Metastatic Breast Cancer —Association With Patient and Disease Characteristics and Effect on Prognosis(2021)78 cited
- → Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registry(2017)66 cited
- → Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors – Data from the German PRAEGNANT breast cancer registry(2017)59 cited
- → Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer — Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany(2020)55 cited